| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.75.1.156 |
| P698 | PubMed publication ID | 2947740 |
| P2093 | author name string | P Théroux | |
| C Léger-Gauthier | |||
| J G Latour | |||
| J De Lara | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | unstable angina | Q2032041 |
| P304 | page(s) | 156-162 | |
| P577 | publication date | 1987-01-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Fibrinopeptide A and platelet factor levels in unstable angina pectoris | |
| P478 | volume | 75 |
| Q74397645 | Activation of coagulation and fibrinolysis after rehabilitative exercise in patients with coronary artery disease |
| Q52480523 | Angioscopic Evaluation of Coronary-Artery Thrombi in Acute Coronary Syndromes |
| Q34441606 | Anticoagulation and the heart |
| Q38020359 | Antithrombotic therapy for coronary artery disease and valvular heart disease |
| Q39612745 | Bimodal presentation of the clinical syndromes of coronary atherosclerosis: a review |
| Q37879482 | Chlamydia pneumoniae: inflammation and instability of the atherosclerotic plaque |
| Q36812008 | Circadian variation in fibrinolytic activity in patients with variant angina |
| Q71993564 | Coagulation Activation in Type 2 Diabetes Mellitus: the Higher Coronary Risk of Female Diabetic Patients |
| Q40795448 | Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects |
| Q41142657 | Coronary hemodynamic effects of systemic thrombolysis in patients with unstable angina |
| Q33781183 | Diagnosis and management of patients with unstable angina |
| Q73364798 | Dynamic Nature of Thrombin Generation, Fibrin Formation, and Platelet Activation in Unstable Angina and Non-Q-Wave Myocardial Infarction |
| Q77644026 | Effect of intravenous heparin infusion on thrombin-antithrombin complex and fibrinopeptide A in unstable angina |
| Q74469436 | Efficacy and safety of early coronary stenting for unstable angina |
| Q74267659 | Enhanced coagulation activation in troponin T-positive unstable angina pectoris |
| Q34000383 | Haemorrheological abnormalities in unstable angina pectoris: a relation independent of risk factor profile and angiographic severity |
| Q36811963 | Importance of thrombosis and thrombolysis in silent ischaemia: comparison of patients with acute myocardial infarction and unstable angina |
| Q73645729 | Increased plasma levels of soluble selectins in patients with unstable angina |
| Q73833794 | Infantile obesity: a situation of atherothrombotic risk? |
| Q42122781 | Influence of power and aerobic exercise training on haemostatic factors after coronary artery surgery |
| Q33611072 | Intracardiac mobile thrombus and D-dimer fragment of fibrin in patients with mitral stenosis |
| Q33801932 | Laboratory Measurement of Thrombin Activity--What Every Clinician Scientist Needs to Know |
| Q73681252 | Lack of Correlation Between Activation of Hemostatic Mechanism and Inflammation in Unstable Angina Pectoris |
| Q44043195 | Lipoprotein (a) blood levels in unstable angina pectoris, acute myocardial infarction, and after thrombolytic therapy |
| Q40602830 | Nitrates for unstable angina |
| Q73295821 | Novel Antithrombotic Strategies for the Treatment of Coronary Artery Thrombosis: A Critical Appraisal |
| Q47647287 | Optimizing the Treatment of Unstable Angina. |
| Q67686317 | Pacing-induced myocardial ischemia does not affect the endothelial release of coagulant and fibrinolytic factors into the coronary circulation |
| Q70150299 | Pathophysiology of unstable angina |
| Q40999481 | Plasma Markers of Procoagulant Activity Among Individuals with Coronary Artery Disease |
| Q61669298 | Plasma level changes of fibrinopeptide a after uncomplicated coronary angioplasty |
| Q45926880 | Plasma plasminogen activator inhibitor activity and tissue plasminogen activator levels in patients with unstable angina and those with coronary spastic angina |
| Q74598115 | Plasma soluble intercellular adhesion molecule-1 levels in coronary circulation in patients with unstable angina |
| Q74574089 | Platelet hyperaggregability persists even after the improvement of increased blood coagulation and impaired fibrinolysis with the stabilization of symptoms in patients with unstable angina |
| Q67883906 | Possible role of vascular intima for generation of coagulant activity in patients undergoing coronary thrombolysis with recombinant tissue-type plasminogen activator. A randomized, placebo-controlled study |
| Q58829366 | Post-meal coagulation activation in diabetes mellitus: the effect of acarbose |
| Q77766255 | Prognostic significance of elevated hemostatic markers in patients with acute myocardial infarction |
| Q33614332 | Raised plasma endothelin in unstable angina and non-Q wave myocardial infarction: relation to cardiovascular outcome |
| Q47281509 | Rationale for the management of coronary syndromes with low-molecular-weight heparins |
| Q79198301 | Relationship between minor myocardial damage and inflammatory acute-phase reaction in acute coronary syndromes |
| Q38215920 | Role of platelet inhibitor therapy in myocardial infarction |
| Q35373672 | Sleep apnoea in ischaemic heart disease: differences between acute and chronic coronary syndromes |
| Q35176153 | The Use of Aspirin in Ischemic Heart Disease |
| Q38568574 | The natural history and epidemiology of venous thrombosis |
| Q47256701 | Thrombotic reactant markers in non-ST segment elevation acute coronary syndromes treated with either enoxaparin (low molecular weight heparin) or unfractionated heparin |
| Q42556891 | Transient thrombotic state after abrupt discontinuation of heparin in percutaneous coronary angioplasty |
Search more.